Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: The cardiovascular health study all stars study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 66 A, Issue 10, 2011, Pages 1100-1107

  Kizer, Jorge R ^a   Arnold, Alice M ^b   Jenny, Nancy S ^c   Cushman, Mary ^c   Strotmeyer, Elsa S ^d   Ives, Diane G ^d   Ding, Jingzhong ^e   Kritchevsky, Stephen B ^e   Chaves, Paulo H M ^f   Hirsch, Calvin H ^g   Newman, Anne B ^d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adiponectin; Aging; C reactive protein; Interleukin 6; Mortality

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHI SQUARE DISTRIBUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; MORTALITY; PREDICTIVE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL; UNITED STATES;

ADIPONECTIN; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MORTALITY; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; UNITED STATES;

EID: 80052903187     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr098     Document Type: Article

References (25)

1. Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128(1):92-105.
2. Chung HY, Cesari M, Anton S, et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009;8(1):18-30.
3. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010;91(1):258S-261S.
4. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 2000;102(11):1296-301.
5. Folco EJ, Rocha VZ, Lopez-Ilasaca M, et al. Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. J Biol Chem. 2009;284(38):25569-25575.
6. Takemura Y, Ouchi N, Shibata R, et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest. 2007;117(2):375-86.
7. Gustafson B, Hammarstedt A, Andersson CX, et al. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(11):2276-2283.
8. Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003;285(3):E527-E533.
9. Kizer JR, Arnold AM, Strotmeyer ES, et al. Change in circulating adiponectin in advanced old age: determinants and impact on functional outcome and mortality. The Cardiovascular Health Study All Stars Study. J Gerontol A Biol Sci Med Sci. 2010;65A(11):1208-1214.
10. Strotmeyer ES, Jenny NS, French B, et al. Does IL-6 track with functional decline? [abstract]. Gerontologist. 2009;49(suppl 2):454.
11. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
12. Newman AB, Arnold AM, Sachs MC, et al. Long-term function in an older cohort-the Cardiovascular Health Study All Stars Study. J Am Geriatr Soc. 2009;57(3):432-440.
13. Cushman M, Cornell ES, Howard PR, et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem. 1995;41(2):264-270.
14. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem. 1997;43(1):52-58.
15. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation. 2003;107(3):499-511.
16. Psaty BM, Kuller LH, Bild D, et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1995;5:270-277.
17. Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol. 1995;5:278-285.
18. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106(5):506-512.
19. Stork S, Feelders RA, van den Beld AW, et al. Prediction of mortality risk in the elderly. Am J Med. 2006;119(6):519-525.
20. Alley DE, Crimmins E, Bandeen-Roche K, et al. Three-year change in inflammatory markers in elderly people and mortality: the Invecchiare in Chianti study. J Am Geriatr Soc. 2007;55(11):1801-1807.
21. Kizer JR, Barzilay JI, Kuller LH, et al. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab. 2008;93(9):3357-3364.
22. Atzmon G, Pollin TI, Crandall J, et al. Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci. 2008;63(5):447-453.
23. Wannamethee SG, Whincup PH, Lennon L, et al. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med. 2007;167(14):1510-1517.
24. Laughlin GA, Barrett-Connor E, May S, et al. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol. 2007;165(2):164-174.
25. Poehls J, Wassel CL, Harris TB, et al. Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study. Diabetologia. 2009;52(4):591-595.